Showing results (121-130 of 135) with videos related to
Sort By:
Pageof 14
Movement Disorders : Official Journal of the Movement Disorder Society|April 18, 2025
Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial PlatformCristina Gonzalez-Robles, Dilan Athauda, Thomas R Barber, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 12, 2025
Hospitalizations as an outcome measure in COURAGE-ALSStacy A Rudnicki, Ammar Al-Chalabi, Jinsy A Andrews, et al.Neurobiology of Aging|December 15, 2022
Whole genome sequencing analysis reveals post-zygotic mutation variability in monozygotic twins discordant for amyotrophic lateral sclerosisGijs H P Tazelaar, Paul J Hop, Meinie Seelen, et al.EMBO Molecular Medicine|November 9, 2017
G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivoRoberto Simone, Rubika Balendra, Thomas G Moens, et al.Nature Communications|January 20, 2023
Integrative genetic analysis illuminates ALS heritability and identifies risk genesSalim Megat, Natalia Mora, Jason Sanogo, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 31, 2023
COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of successJeremy M Shefner, Ammar Al-Chalabi, Jinsy A Andrews, et al.The Lancet. Neurology|May 23, 2024
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialMichael Benatar, Thomas Hansen, Dror Rom, et al.Ebiomedicine|October 11, 2025
Optimised machine learning for time-to-event prediction in healthcare applied to timing of gastrostomy in ALS: a multi-centre, retrospective model development and validation studyMarcel Weinreich, Harry McDonough, Mark Heverin, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 5, 2015
The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's diseaseChristina M Lill, Aina Rengmark, Lasse Pihlstrøm, et al.Frontiers in Cellular Neuroscience|January 2, 2023
Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence dataAhmad Al Khleifat, Alfredo Iacoangeli, Ashley R Jones, et al.Pageof 14